Incyte Corporation has a total of 6693 patents globally, out of which 2153 have been granted. Of these 6693 patents, more than 58% patents are active. United States of America is where Incyte Corporation has filed the maximum number of patents, followed by Australia and Europe. Parallelly, USA seems to be the main focused R&D center and is also the origin country of Incyte Corporation.
Incyte Corporation was founded in 1991 by Randy Scott. Incyte Corporation is a biopharmaceutical company. The Company discovers, develops, and commercializes proprietary small molecule drugs, primarily used in oncology. As of March 2021, Incyte Corporation has a market cap of $16.29 Billion.
Do read about some of the most popular patents of Incyte Corporation which have been covered by us in this article and also you can find Incyte Corporation patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Incyte Corporation patent portfolio.
How many patents does the CEO of Incyte Corporation have?
The CEO, Randy Scott have 0 patents.
How many patents does Incyte Corporation have?
Incyte Corporation has a total of 6693 patents globally. These patents belong to 1062 unique patent families. Out of 6693 patents, 3945 patents are active.
How many Incyte Corporation patents are Alive/Dead?
Worldwide Patents
Patent Families
How Many Patents did Incyte Corporation File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Incyte Applications Filed | Incyte Patents Granted |
| 2011 | 222 | 62 |
| 2012 | 203 | 89 |
| 2013 | 187 | 102 |
| 2014 | 461 | 122 |
| 2015 | 351 | 135 |
| 2016 | 388 | 170 |
| 2017 | 300 | 195 |
| 2018 | 220 | 199 |
| 2019 | 510 | 226 |
| 2020 | 342 | 270 |
| 2021 | 180 | 275 |
| 2022 | – | 44 |
Explore the top-performing drugs that dominate the Pharmaceutical Industry
| Patent Number | Company | Product | Brand | Revenue | Patent Expiry Date |
| US9174975 | Sumitomo Pharma | Lurasidone Hydrochloride | Latuda | $1.75B | Jun-26 |
| US7612199 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US7902206 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US8158644 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US7371727 | Ironwood Pharma | Linaclotide | Linzess | $1.00B | Mar-25 |
Want to know which drugs are making over $1 Billion annually?
How Many Patents did Incyte Corporation File in Different Countries?
Countries in which Incyte Corporation Filed Patents
| Country | Patents |
| United States Of America | 1137 |
| Australia | 533 |
| Europe | 488 |
| Japan | 462 |
| Taiwan | 179 |
| Hong Kong (S.A.R.) | 173 |
| Canada | 167 |
| Singapore | 162 |
| Korea (South) | 148 |
| Israel | 147 |
| Mexico | 127 |
| Eurasian Patent Organization | 120 |
| Argentina | 117 |
| Brazil | 113 |
| India | 110 |
| Indonesia | 105 |
| Philippines | 104 |
| Germany | 101 |
| Viet Nam | 100 |
| China | 97 |
| Malaysia | 97 |
| Spain | 96 |
| New Zealand | 92 |
| Chile | 92 |
| Costa Rica | 91 |
| Peru | 73 |
| Ecuador | 64 |
| Portugal | 59 |
| Poland | 57 |
| Denmark | 57 |
| Serbia | 57 |
| Croatia | 55 |
| Slovenia | 55 |
| Colombia | 51 |
| Hungary | 50 |
| Lithuania | 40 |
| Cyprus | 37 |
| South Africa | 35 |
| Montenegro | 27 |
| Norway | 24 |
| Ukraine | 23 |
| Georgia | 15 |
| Morocco | 14 |
| Tunisia | 9 |
| San Marino | 8 |
| Jordan | 7 |
| Cuba | 6 |
| Austria | 6 |
| Mongolia | 5 |
| Russian Federation | 4 |
| Dominican Republic | 4 |
| Turkey | 4 |
| Netherlands | 3 |
| Nicaragua | 3 |
| Brunei | 3 |
| Iceland | 3 |
| Sweden | 3 |
| African Regional Industrial Property Organization | 3 |
| Panama | 2 |
| Uruguay | 2 |
| El Salvador | 2 |
| Republic of Moldova | 2 |
| Luxembourg | 1 |
| Gulf Cooperation Council | 1 |
| Honduras | 1 |
| United Arab Emirates | 1 |
Where are Research Centers of Incyte Corporation Patents Located?
10 Best Incyte Corporation Patents
WO2007070514A1 is the most popular patent in the Incyte Corporation portfolio. It has received 525 citations so far from companies like Japan Tobacco, Novartis and Bicyclerd Limited.
Below is the list of 10 most cited patents of Incyte Corporation:
| Publication Number | Citation Count |
| WO2007070514A1 | 525 |
| WO2009114512A1 | 380 |
| WO2006122150A1 | 340 |
| US20030064397A1 | 287 |
| WO2008064157A1 | 270 |
| WO2002072596A1 | 233 |
| WO2008036653A2 | 230 |
| US6553317B1 | 218 |
| US6645499B1 | 211 |
| US20070208001A1 | 194 |
What Percentage of Incyte Corporation US Patent Applications were Granted?
Incyte Corporation (Excluding its subsidiaries) has filed 1471 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 839 have been granted leading to a grant rate of 68.49%.
Below are the key stats of Incyte Corporation patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Incyte Corporation?
| Law Firm | Total Applications | Success Rate |
| Fish & Richardson Pc | 499 | 79.33% |
| Incyte Corporation | 385 | 70.34% |
| Foley & Lardner Llp | 239 | 54.43% |
| Cozen O Connor Pc | 28 | 0% |
| Lathrop Gpm Llp | 27 | 77.78% |
| Michael C Cerrone | 13 | 0% |
| Pepper Hamilton Llp | 12 | 80.00% |
| Richard Aron Osman | 11 | 81.82% |
| Bozicevic Field & Francis Llp | 8 | 100.00% |
| Christine A Goddard Ph D | 6 | 0% |
EXCLUSIVE INSIGHTS COMING SOON!
What are Incyte Corporation‘s key innovation segments?
What Technologies are Covered by Incyte Corporation?
The chart below distributes patents filed by Incyte Corporation in different countries on the basis of the technology protected in patents. It also represents the markets where Incyte Corporation thinks it’s important to protect particular technology inventions.
R&D Focus: How Incyte Corporation search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Incyte Corporation?